Gen-Probe Slaps BD with Second Infringement Suit Related to Molecular Dx Instruments

The latest suit alleges that the BD Max system infringes upon several patents owned by Gen-Probe and related to its Tigris molecular diagnostics blood-screening system.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.